SCHEMBL23309606

SCHEMBL23309606

N#Cc1ccccc1OC(=O)c1cc(F)nc(F)c1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 5/20 0.38
▸ POLB P06746 1/20 0.37
▸ GAA P10253 1/20 0.35
▸ HPGD P15428 2/20 0.35
▸ NPSR1 Q6W5P4 3/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ GPR55 Q9Y2T6 1/20 0.35
▸ ALDH1A1 P00352 4/20 0.34
▸ KDM4E B2RXH2 3/20 0.34
▸ NPC1 O15118 2/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ CYP1A2 P05177 2/20 0.34
▸ CYP2C9 P11712 2/20 0.34
▸ CYP2C19 P33261 2/20 0.34
▸ TSHR P16473 1/20 0.34
▸ LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309596 0.80 MAPT (0.51) SMN1; SMN2POLBHPGDNPSR1KMT2A
SCHEMBL23309607 0.76 MAPT (0.49) SMN1; SMN2POLBHPGDNPSR1KMT2A
SCHEMBL23309722 0.76 POLB (0.45) SMN1; SMN2POLBGAAKMT2AMEN1
SCHEMBL23309709 0.74 EPHB3 (0.50) SMN1; SMN2POLBGAAKMT2AL3MBTL1
SCHEMBL734780 0.72 ALDH1A1 (0.41) SMN1; SMN2POLBGAAHPGDNPSR1
SCHEMBL755202 0.71 KMT2A (0.47) SMN1; SMN2POLBGAAHPGDKMT2A
SCHEMBL11443998 0.70 SLC6A3 (0.60) SMN1; SMN2GAAHPGDNPSR1KMT2A
SCHEMBL6567956 0.70 KMT2A (0.58) SMN1; SMN2POLBGAANPSR1KMT2A
SCHEMBL23309649 0.69 HTT (0.46) SMN1; SMN2NPSR1KMT2AMEN1TP53
SCHEMBL11431485 0.69 SCN1A (0.46) SMN1; SMN2HPGDKMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL SMN1; SMN2 3893/4885POLB 1411/4885GAA 75/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback